1-19 of 19
Yoav H. Messinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231

CME Clinical Trials & Observations Brief Report
Robert J. Hayashi, Michelle L. Hermiston, Brent L. Wood, David T. Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D. Annett, Barbara L. Asselin, Keith August, Steve Cho, Kimberly P. Dunsmore, Jason Lawrence Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir Patel, Eric S. Schafer, Tal Schechter, Kristin A. Shimano, Neelam Singh, Amii Steele, Maria L. Sulis, Sarah L. Vargas, Stuart S. Winter, Charlotte Wood, Patrick A. Zweidler-McKay, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, Catherine M. Bollard, Carl E. Allen
Journal: Blood
Blood (2024) 143 (20): 2053–2058.
https://doi.org/10.1182/blood.2023021184
Published: 2024
Includes: Supplemental data
Journal Articles

Outcome of Infants Treated on Total Therapy for Infants with Acute Lymphoblastic Leukemia I: Results from a Non-Randomized Multi-Center Study

Tanja A. Gruber, Minxuan Huang, Sima Jeha, Rebecca J. Deyell, Victor A. Lewis, Bill H. Chang, Eric J. Lowe, Jamie Frediani, Catherine Vezina, Bruno Michon, Nathan Gossai, Erin H. Breese, Thai Hoa Tran, Norman J. Lacayo, Christine Bolen, Sunil J. Desai, Jennifer L. Pauley, Emily Ashcraft, Cheng Cheng, Kirk R. Schultz, Krysta Schils, Linda C. Stork, Van Thu Huynh, Michael Richards, Yoav H. Messinger, Henrique Bittencourt, Terzah M. Horton, Uma Athale, Duncan Stearns, Deborah E. Schiff, Paul S. Gaynon
Journal: Blood
Blood (2023) 142 (Supplement 1): 823.
https://doi.org/10.1182/blood-2023-177798
Published: 2023
Journal Articles

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Robert J. Hayashi, Michelle L. Hermiston, David T. Teachey, Meenakshi Devidas, Brent L. Wood, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Y Cho, Kimberly P. Dunsmore, Jason L. Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok I Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir I Patel, Eric S Schafer, Tal Schechter-Finkelstein, Kristin A. Shimano, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah L Vargas, Stuart S. Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, Catherine M Bollard, Carl Allen
Journal: Blood
Blood (2022) 140 (Supplement 1): 6387–6389.
https://doi.org/10.1182/blood-2022-159694
Published: 2022
Journal Articles

The Cost of Cellular Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia: A Commercial Insurance Claims Database Analysis

Alex Hoover, Paige Reimche, Dave Watson, Mike Finch, Laura Gilchrist, Lynn Tanner, Yoav H. Messinger, Lucie M Turcotte
Journal: Blood
Blood (2022) 140 (Supplement 1): 7913–7914.
https://doi.org/10.1182/blood-2022-159895
Published: 2022
Journal Articles

Intensification of Chemotherapy Using a Modified BFM Backbone for Children, Adolescents and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Identifies Highly Chemorefractory Patients Who Benefit from Allogeneic Hematopoietic Stem Cell Transplantation

Paul Harker-Murray, Brent L. Wood, Meenakshi Devidas, Zhiguo Chen, Tal Schechter-Finkelstein, Robert J. Hayashi, Keith J August, Kimberly P. Dunsmore, Michelle L. Hermiston, Terzah M. Horton, Yoav H. Messinger, Sarah L Vargas, Eric S Schafer, Maria Luisa Sulis, Stuart S. Winter, Charlotte Wood, Catherine M Bollard, Mignon L. Loh, Stephen P Hunger, Elizabeth A. Raetz, David T. Teachey
Journal: Blood
Blood (2021) 138 (Supplement 1): 3487.
https://doi.org/10.1182/blood-2021-151837
Published: 2021
Journal Articles

Cost of Pediatric Acute Lymphoblastic Leukemia Care in the Current Treatment Era

Lucie M Turcotte, Caleb Hocutt, Yoav H. Messinger, Laura Gilchrist, Dave Watson, Mike Finch
Journal: Blood
Blood (2021) 138 (Supplement 1): 663.
https://doi.org/10.1182/blood-2021-146621
Published: 2021
Journal Articles

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

David T. Teachey, MD, Meenakshi Devidas, PhD, Brent L Wood, MD PhD, Zhiguo Chen, MS, Robert James Hayashi, MD, Robert D Annett, PhD, Barbara L Asselin, MD, Keith J August, MDMS, Steve Y Cho, MD, Kimberly P. Dunsmore, MD, Brian T. Fisher, DO, MSCE, Jason L. Freedman, MD, Paul J. Galardy, MD, Paul Harker-Murray, MD PhD, Michelle L. Hermiston, MD PhD, Terzah M Horton, MD PhD, Alok I Jaju, MD, Allison Lam, BCPS, Yoav H. Messinger, MD, Rodney R. Miles, MD PhD, Maki Okada, RN, Samir I Patel, MD, Eric S. Schafer, MD MHS, Tal Schechter-Finkelstein, MD, Kristin A. Shimano, MD, Neelam Singh, PhD, Amii C. Steele, PhD, Maria L. Sulis, MD, Sarah L Vargas, PhD, Stuart S. Winter, MD, Charlotte Wood, CCRP, Patrick Zweider McKay, MDPhD, Catherine M. Bollard, MD MBChB, Mignon L. Loh, MD, Stephen P. Hunger, MD, Elizabeth A. Raetz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134730
Published: 2020
Journal Articles

Bvgp: A Novel Protocol for Hodgkin's with Excellent Response, Minimal Acute Toxicities and Reduced Risk of Late Effects

Bruce Bostrom, MD, Nathan Gossai, MD, Joanna Lee Perkins, MPH, MD, Michael Richards, MD PhD, Yoav H. Messinger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5192.
https://doi.org/10.1182/blood.V130.Suppl_1.5192.5192
Published: 2017
Journal Articles

The Association of Plasma and Cerebral Spinal Fluid Cytokines with Daytime Sleepiness Among Children with Acute Lymphoblastic Leukemia

Jill Dreyfus, PhD, M.P.H., Anne Harris, M.P.H., Angela Panoskaltsis-Mortari, PhD, James Krueger, PhD, Gerald Rosen, MD, Yoav H Messinger, MD
Journal: Blood
Blood (2014) 124 (21): 2263.
https://doi.org/10.1182/blood.V124.21.2263.2263
Published: 2014
Journal Articles

Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)

James Whitlock, Luciano dalla Pozza, MBBS, FRACP, John M Goldberg, MD, Lewis B. Silverman, MD, David S. Ziegler, MBBS, FRACP, MD, Andishe Attarbaschi, MD, Patrick Brown, MD, Rebecca A Gardner, MD, Paul S. Gaynon, MD, Raymond J. Hutchinson, MD, Leigh J. Marcus, MD, Yoav H. Messinger, MD, Kirk R. Schultz, MD, Jeannette Vandergiessen, BA, CCRP, Elena Eckroth, CCRC, Franco Locatelli, C Michel Zwaan, Brent L. Wood, MD PhD, Richard Sposto, PhD, Lia Gore, MD
Journal: Blood
Blood (2014) 124 (21): 795.
https://doi.org/10.1182/blood.V124.21.795.795
Published: 2014
Journal Articles

A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Weili Sun, MDPhD, Paul S Gaynon, MD, Richard Sposto, PhD, Henrique Bittencourt, MD, Andrew E. Place, MDPhD, Yoav H Messinger, MD, Chris Fraser, MD, Luciano Dalla-Pozza, MD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Xiaojing Yang, PhD, Gangning Liang, PhD, Peter A. Jones, PhD DSc, Alan S. Wayne, MD, Todd Cooper, DO
Journal: Blood
Blood (2014) 124 (21): 3764.
https://doi.org/10.1182/blood.V124.21.3764.3764
Published: 2014
Journal Articles

A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute Leukemia

John M Goldberg, MD, Julia Glade-Bender, MD, Maria Luisa Sulis, MD, Rebecca A Gardner, MD, Jessica A. Pollard, MD, Victor Aquino, MD, Naomi J. Winick, MD, Bruce C. Bostrom, MD, Cecilia Fu, MD, Raymond J. Hutchinson, MD, Thomas J. Manley, MD, Rajen Mody, MD MS, Javier Oesterheld, MD, Blythe Thomson, MD, Julie R Park, MD, Jeannette Cassar, Elena Eckroth, CCRC, Richard Sposto, PhD, Yoav H Messinger, MD, Nobuko HiJiya, MD, Paul S Gaynon, MD, Julio C. Barredo, MD
Journal: Blood
Blood (2014) 124 (21): 3705.
https://doi.org/10.1182/blood.V124.21.3705.3705
Published: 2014
Journal Articles

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Lynda M. Vrooman, MD, Ivan I. Kirov, MD, Zoann E. Dreyer, MD, Michael Kelly, MD, PhD, Nobuko Hijiya, MD, Patrick Brown, MD, Richard A. Drachtman, MD, Yoav H Messinger, MD, A. Kim Ritchey, MD, Gregory A. Hale, MD, Kelly Maloney, MD, Paul V. Plourde, MD, Lewis B. Silverman, MD
Journal: Blood
Blood (2013) 122 (21): 3904.
https://doi.org/10.1182/blood.V122.21.3904.3904
Published: 2013
Journal Articles

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Clinical Trials & Observations
Yoav H. Messinger, Paul S. Gaynon, Richard Sposto, Jeannette van der Giessen, Elena Eckroth, Jemily Malvar, Bruce C. Bostrom
Journal: Blood
Blood (2012) 120 (2): 285–290.
https://doi.org/10.1182/blood-2012-04-418640
Published: 2012
Includes: Supplemental data
Journal Articles

Bortezomib Combined with VXLD Chemotherapy Is Highly Effective In Advanced B-Lineage Acute Lymphoblastic Leukemia Allowing Early Study Termination Due to Efficacy. A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Phase II Study

Yoav H Messinger, MD, Paul Gaynon, MD, Richard Sposto, Ph.D., Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Jemily Malvar, M.S., Bruce C. Bostrom, MD
Journal: Blood
Blood (2011) 118 (21): 251.
https://doi.org/10.1182/blood.V118.21.251.251
Published: 2011
Journal Articles

Cardiometabolic Risks Among Survivors of Childhood Hematologic Malignancies.

Daniel A. Mulrooney, MD, MS, Aaron Kelly, Ph.D., K. Scott Baker, Lyn Steffen, Ph.D., Jill Lunsford-Lee, PNP, Anna Petryk, MD, Alan R. Sinaiko, MD, Donald R. Dengel, PhD, Joanna Perkins, Yoav H. Messinger, MD, Xia Zhou, Julia Steinberger, MD, MS
Journal: Blood
Blood (2009) 114 (22): 4113.
https://doi.org/10.1182/blood.V114.22.4113.4113
Published: 2009
Journal Articles

Remarkable Activity of Bortezomib Combined with Chemotherapy in a Phase I Study of Relapsed Childhood Acute Lymphoblastic Leukemia (ALL). A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Yoav H. Messinger, MD, Paul S. Gaynon, MD, Elizabeth Raetz, MD, Raymond Hutchinson, MD, MS, Steven DuBois, MD, Julia Glade Bender, MD, Richard Sposto, PhD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Bruce C. Bostrom, MD
Journal: Blood
Blood (2008) 112 (11): 1919.
https://doi.org/10.1182/blood.V112.11.1919.1919
Published: 2008
Journal Articles

Acute Lymphoblastic Leukemia (ALL) with t(8;14)(q11.2;q32): B-Lineage Disease with High Proportion of Down Syndrome. A Children’s Oncology Group (COG) Study.

Yoav H. Messinger, MD, Rodney Higgins, PhD, Meenakshi Devidas, PhD, Stephen P. Hunger, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD
Journal: Blood
Blood (2008) 112 (11): 1477.
https://doi.org/10.1182/blood.V112.11.1477.1477
Published: 2008
Journal Articles

CD52 Is Expressed in Childhood Acute Myeloid Leukemia and May Be a Target for Alemtuzumab.

Matthew K. Wegmann, James Berger, CLS-ASCP, Bruce Bostrom, MD, Yoav H. Messinger, MD
Journal: Blood
Blood (2007) 110 (11): 4316.
https://doi.org/10.1182/blood.V110.11.4316.4316
Published: 2007